BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ma YY, Shi JJ, Chen JB, Xu KC, Niu LZ. Irreversible electroporation for liver metastasis from pancreatic cancer: A case report. World J Clin Cases 2020; 8(2): 390-397 [PMID: 32047790 DOI: 10.12998/wjcc.v8.i2.390] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Xiong F, Wu GH, Wang B, Chen YJ. Plastin-3 is a diagnostic and prognostic marker for pancreatic adenocarcinoma and distinguishes from diffuse large B-cell lymphoma. Cancer Cell Int 2021;21:411. [PMID: 34348730 DOI: 10.1186/s12935-021-02117-1] [Reference Citation Analysis]
2 Eresen A, Yang J, Scotti A, Cai K, Yaghmai V, Zhang Z. Combination of natural killer cell-based immunotherapy and irreversible electroporation for the treatment of hepatocellular carcinoma. Ann Transl Med 2021;9:1089. [PMID: 34423001 DOI: 10.21037/atm-21-539] [Reference Citation Analysis]
3 Maglietti F, Tellado M, De Robertis M, Michinski S, Fernández J, Signori E, Marshall G. Electroporation as the Immunotherapy Strategy for Cancer in Veterinary Medicine: State of the Art in Latin America. Vaccines (Basel) 2020;8:E537. [PMID: 32957424 DOI: 10.3390/vaccines8030537] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4 Zhang WT, Zhang JJ, Shao Q, Wang YK, Jia JP, Qian B, Tian XW, Yan WJ. FGD5‑AS1 is an oncogenic lncRNA in pancreatic cancer and regulates the Wnt/β‑catenin signaling pathway via miR‑577. Oncol Rep 2022;47:21. [PMID: 34821374 DOI: 10.3892/or.2021.8232] [Reference Citation Analysis]